Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death.

Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, Okumura K, Yagita H.

J Immunol. 2003 Jan 1;170(1):341-8.

2.

TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.

Wiley SR, Winkles JA.

Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):241-9. Review.

PMID:
12787562
3.

TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.

Burkly LC, Michaelson JS, Hahm K, Jakubowski A, Zheng TS.

Cytokine. 2007 Oct;40(1):1-16. Epub 2007 Nov 5. Review.

PMID:
17981048
4.

TWEAK and Fn14: new molecular targets for cancer therapy?

Winkles JA, Tran NL, Berens ME.

Cancer Lett. 2006 Apr 8;235(1):11-7. Review.

PMID:
15885893
5.

Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases.

Yepes M, Winkles JA.

Drug News Perspect. 2006 Dec;19(10):589-95. Review.

PMID:
17299600
6.

Role of TWEAK and Fn14 in tumor biology.

Winkles JA, Tran NL, Brown SA, Stains N, Cunliffe HE, Berens ME.

Front Biosci. 2007 Jan 1;12:2761-71. Review.

PMID:
17127278
7.

TWEAKing renal injury.

Sanz AB, Moreno JA, Sanchez-Nino MD, Ucero AC, Benito A, Santamaria B, Justo P, Izquierdo MC, Egido J, Blanco-Colio LM, Ortiz A.

Front Biosci. 2008 Jan 1;13:580-9. Review.

PMID:
17981571
8.

Tweak and FN14 in central nervous system health and disease.

Yepes M.

Front Biosci. 2007 May 1;12:2772-81. Review.

PMID:
17485258
9.

TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses.

Burkly LC, Michaelson JS, Zheng TS.

Immunol Rev. 2011 Nov;244(1):99-114. doi: 10.1111/j.1600-065X.2011.01054.x. Review.

PMID:
22017434
10.

Role of tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in rheumatic diseases.

Zhu LX, Zhang HH, Mei YF, Zhao YP, Zhang ZY.

Chin Med J (Engl). 2012 Nov;125(21):3898-904. Review.

PMID:
23106895
11.

The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.

Campbell S, Michaelson J, Burkly L, Putterman C.

Front Biosci. 2004 Sep 1;9:2273-84. Review.

PMID:
15353286
12.

Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway.

Michaelson JS, Burkly LC.

Results Probl Cell Differ. 2009;49:145-60. doi: 10.1007/400_2008_18. Review.

PMID:
19513634
13.

Considering TWEAK as a target for therapy in renal and vascular injury.

Ortiz A, Sanz AB, Muñoz García B, Moreno JA, Sánchez Niño MD, Martín-Ventura JL, Egido J, Blanco-Colio LM.

Cytokine Growth Factor Rev. 2009 Jun;20(3):251-8. doi: 10.1016/j.cytogfr.2009.05.002. Epub 2009 May 30. Review.

PMID:
19482507
14.

The TWEAK-Fn14 system as a potential drug target.

Wajant H.

Br J Pharmacol. 2013 Oct;170(4):748-64. doi: 10.1111/bph.12337. Review.

15.

TWEAK/Fn14 signaling in tumors.

Hu G, Zeng W, Xia Y.

Tumour Biol. 2017 Jun;39(6):1010428317714624. doi: 10.1177/1010428317714624. Review.

PMID:
28639899
16.

Tumor Necrosis Factor Receptor Mediates Fibroblast Growth Factor-Inducible 14 Signaling.

Wang X, Xiao S, Xia Y.

Cell Physiol Biochem. 2017;43(2):579-588. doi: 10.1159/000480530. Epub 2017 Sep 21. Review.

17.

A further TWEAK to multiple sclerosis pathophysiology.

Nazeri A, Heydarpour P, Sadaghiani S, Sahraian MA, Burkly LC, Bar-Or A.

Mol Neurobiol. 2014 Feb;49(1):78-87. doi: 10.1007/s12035-013-8490-y. Epub 2013 Jul 20. Review.

PMID:
23873135
18.

The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases: focus on inflammatory bowel diseases.

Dohi T, Burkly LC.

J Leukoc Biol. 2012 Aug;92(2):265-79. doi: 10.1189/jlb.0112042. Epub 2012 Jun 6. Review.

PMID:
22672874
19.

TWEAK/Fn14 signaling: a promising target in intervertebral disc degeneration.

Liu YP, Yuan CM, Zhang SG, Hao QH, Wang MM, Zhang Z, Meng Q, Li M, Hao YD.

Histol Histopathol. 2016 Sep;31(9):943-8. doi: 10.14670/HH-11-775. Epub 2016 Feb 24. Review.

PMID:
26907852
20.

TWEAK/Fn14 axis: the current paradigm of tissue injury-inducible function in the midst of complexities.

Burkly LC.

Semin Immunol. 2014 Jun;26(3):229-36. doi: 10.1016/j.smim.2014.02.006. Epub 2014 Mar 11. Review.

PMID:
24636536

Supplemental Content

Support Center